DrugUse-v3.2(2018EN): verschil tussen versies
(Nieuwe pagina aangemaakt met '<!-- Hieronder wordt een transclude page aangeroepen --> {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.7.4(EN)|1|DrugUse-v3.2(2018EN)}} <!-- Tot hier de transclud...') |
Geen bewerkingssamenvatting |
||
Regel 199: | Regel 199: | ||
==Information Model== | ==Information Model== | ||
<BR> | <BR> | ||
<imagemap> Bestand:DrugUse-v3.2Model( | <imagemap> Bestand:DrugUse-v3.2Model(2018EN).png | center | ||
rect | rect 525 247 670 317 [[#11349]] | ||
rect | rect 702 257 879 307 [[#RouteOfAdministrationCodelist]] | ||
rect | rect 703 157 880 207 [[#DrugUseStatusCodelist]] | ||
rect | rect 357 366 447 436 [[#11356]] | ||
rect | rect 341 241 465 311 [[#11342]] | ||
rect | rect 702 56 911 106 [[#TypeOfDrugOrMedicationCodelist]] | ||
rect | rect 525 145 670 215 [[#11347]] | ||
rect | rect 525 49 670 119 [[#11354]] | ||
rect | rect 176 314 270 384 [[#11335]] | ||
rect | rect 176 216 270 286 [[#11352]] | ||
rect | rect 340 113 464 194 [[#11336]] | ||
rect | rect 176 118 270 188 [[#11333]] | ||
desc none | desc none | ||
</imagemap> | </imagemap> | ||
Regel 384: | Regel 384: | ||
|Description<!--vsDescription--> | |Description<!--vsDescription--> | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Misbruikt drugs" >Misuses drugs</span> | |<span title = "Misbruikt drugs">Misuses drugs</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=361055000 361055000] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=361055000 361055000] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 396: | Regel 396: | ||
|gebruikt geen drugs | |gebruikt geen drugs | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Heeft nooit drugs misbruikt" >Has never misused drugs</span> | |<span title = "Heeft nooit drugs misbruikt">Has never misused drugs</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228368007 228368007] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=228368007 228368007] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 402: | Regel 402: | ||
|heeft nooit drugs gebruikt | |heeft nooit drugs gebruikt | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Heeft in het verleden drugs misbruikt" >Misused drugs in past</span> | |<span title = "Heeft in het verleden drugs misbruikt">Misused drugs in past</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=44870007 44870007] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=44870007 44870007] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 470: | Regel 470: | ||
|Description<!--vsDescription--> | |Description<!--vsDescription--> | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Heroïne" >Diamorphine</span> | |<span title = "Heroïne">Diamorphine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387341002 387341002] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 476: | Regel 476: | ||
|Heroïne | |Heroïne | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Benzodiazepine" >Benzodiazepine</span> | |<span title = "Benzodiazepine">Benzodiazepine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372664007 372664007] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372664007 372664007] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 482: | Regel 482: | ||
|Benzodiazepine | |Benzodiazepine | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Methadon" >Methadone</span> | |<span title = "Methadon">Methadone</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387286002 387286002] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387286002 387286002] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 488: | Regel 488: | ||
|Methadon | |Methadon | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Gammahydroxyboterzuur" >Hydroxybutyric acid</span> | |<span title = "Gammahydroxyboterzuur">Hydroxybutyric acid</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62821004 62821004] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=62821004 62821004] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 494: | Regel 494: | ||
|GHB | |GHB | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Cocaïne" >Cocaine</span> | |<span title = "Cocaïne">Cocaine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387085005 387085005] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 500: | Regel 500: | ||
|Cocaïne | |Cocaïne | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Crack" >Cocaine freebase</span> | |<span title = "Crack">Cocaine freebase</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229003004 229003004] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229003004 229003004] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 506: | Regel 506: | ||
|Crack, base coke | |Crack, base coke | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Methyleendioxymethamfetamine" >Methylenedioxymethamphetamine</span> | |<span title = "Methyleendioxymethamfetamine">Methylenedioxymethamphetamine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=288459003 288459003] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=288459003 288459003] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 512: | Regel 512: | ||
|MDMA | |MDMA | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Amfetamine" >Amphetamine</span> | |<span title = "Amfetamine">Amphetamine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=703842006 703842006] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=703842006 703842006] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 518: | Regel 518: | ||
|Amfetamine, speed | |Amfetamine, speed | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Cannabis" >Cannabis</span> | |<span title = "Cannabis">Cannabis</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=398705004 398705004] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=398705004 398705004] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 524: | Regel 524: | ||
|Cannabis, wiet marihuana, hasj | |Cannabis, wiet marihuana, hasj | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Paddo" >Hallucinogenic mushrooms</span> | |<span title = "Paddo">Hallucinogenic mushrooms</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229006007 229006007] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=229006007 229006007] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 530: | Regel 530: | ||
|Paddo''s | |Paddo''s | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Lyserginezuurdi-ethylamide" >Lysergic acid diethylamide</span> | |<span title = "Lyserginezuurdi-ethylamide">Lysergic acid diethylamide</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=15698006 15698006] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=15698006 15698006] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 536: | Regel 536: | ||
|LSD | |LSD | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Ketamine" >Ketamine</span> | |<span title = "Ketamine">Ketamine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373464007 373464007] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=373464007 373464007] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 542: | Regel 542: | ||
|Ketamine | |Ketamine | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Fencyclidine" >Phencyclidine</span> | |<span title = "Fencyclidine">Phencyclidine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=9721008 9721008] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=9721008 9721008] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 548: | Regel 548: | ||
|PCP | |PCP | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Methamfetamine" >Metamfetamine</span> | |<span title = "Methamfetamine">Metamfetamine</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387499002 387499002] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=387499002 387499002] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 554: | Regel 554: | ||
|Crystal meth, methamfetamine | |Crystal meth, methamfetamine | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Anabool steroïd" >Anabolic steroid</span> | |<span title = "Anabool steroïd">Anabolic steroid</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=111151007 111151007] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 560: | Regel 560: | ||
|Anabole steroïde | |Anabole steroïde | ||
|-style="vertical-align:top; " | |-style="vertical-align:top; " | ||
|<span title = "Laxans" >Laxative</span> | |<span title = "Laxans">Laxative</span> | ||
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372800002 372800002] | |[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=372800002 372800002] | ||
|SNOMED CT | |SNOMED CT | ||
Regel 598: | Regel 598: | ||
====This information model refers to<!--ftRefersTo-->==== | ====This information model refers to<!--ftRefersTo-->==== | ||
:-- | :-- | ||
====This | ====This information model is used in<!--ftReferredBy-->==== | ||
:-- | :-- | ||
==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->== | ==Technical specifications in HL7v3 CDA and HL7 FHIR<!--ftHeader-->== | ||
Regel 617: | Regel 617: | ||
</ul> | </ul> | ||
Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR> | Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR> | ||
This page is generated on | This page is generated on 23/12/2018 01:17:22 with ZibExtraction v. 3.0.6929.24609<!--ftDate--> <BR> | ||
----- | ----- | ||
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2018(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2018(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div> | <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2018(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2018(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div> |
Versie van 24 dec 2018 12:56
General information
Name: nl.zorg.DrugUse
Version: 3.2
HCIM Status:Final
Release: 2018
Release status: Prepublished
Release date: 01-10-2018
Metadata
DCM::CoderList | Kerngroep Registratie aan de Bron |
DCM::ContactInformation.Address | * |
DCM::ContactInformation.Name | * |
DCM::ContactInformation.Telecom | * |
DCM::ContentAuthorList | Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron |
DCM::CreationDate | 5-7-2012 |
DCM::DeprecatedDate | |
DCM::DescriptionLanguage | nl |
DCM::EndorsingAuthority.Address | |
DCM::EndorsingAuthority.Name | PM |
DCM::EndorsingAuthority.Telecom | |
DCM::Id | 2.16.840.1.113883.2.4.3.11.60.40.3.7.4 |
DCM::KeywordList | drugsgebruik, verdovende middelen, middelen gebruik, drugs |
DCM::LifecycleStatus | Final |
DCM::ModelerList | Kerngroep Registratie aan de Bron |
DCM::Name | nl.zorg.DrugsGebruik |
DCM::PublicationDate | 01-10-2018 |
DCM::PublicationStatus | Prepublished |
DCM::ReviewerList | Projectgroep Generieke Overdrachtsgegevens & Kerngroep Registratie aan de Bron |
DCM::RevisionDate | 31-12-2017 |
DCM::Superseeds | nl.zorg.DrugsGebruik-v3.1 |
DCM::Version | 3.2 |
HCIM::PublicationLanguage | EN |
Revision History
Only available in Dutch
Publicatieversie 1.0 (15-02-2013)
Publicatieversie 1.1 (01-07-2013)
Publicatieversie 1.2 (01-04-2015)
ZIB-138 | Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsGebruikStatusCodelijst n.a.v. review terminologie expert. |
ZIB-139 | Aanpassingen in SNOMED CT codes en omschrijvingen voor codelijst DrugsOfGeneesmiddelSoortCodelijst n.a.v. review terminologie expert. |
ZIB-158 | Cardinaliteit SoortMiddel aanpassen in bouwsteen OverdrachtDrugsgebruik |
ZIB-161 | Het concept Hoeveelheid van bouwsteen OverdrachtDrugsgebruik. |
ZIB-167 | Bevindingen Concept inrichting Intoxicatie Roken/ Alcohol en Drugs in EZIS.NET |
ZIB-224 | In de klinische bouwsteen OverdrachtDrugsgebruik, concept SoortMiddel komt tagged value DrugsOfGeneesmiddelSoortCodelijst niet overeen met naam gekoppelde valueset DrugsOfGeneesmiddelSoort. |
ZIB-225 | In de klinische bouwsteen OverdrachtDrugsgebruik, concept ToedieningsWeg komt tagged value ToedieningsWegCodelijst niet overeen met naam gekoppelde valueset. |
ZIB-308 | Prefix Overdracht weggehaald bij de generieke bouwstenen |
ZIB-312 | aanpassing paragraaf 'Concept' |
ZIB-313 | Aanpassen paragraaf 'Purpose' |
ZIB-316 | Paragraaf 'Evidence base' wijzigen |
ZIB-319 | Wijzing paragraaf Constraint |
Incl. algemene wijzigingsverzoeken:
ZIB-94 | Aanpassen tekst van Disclaimer, Terms of Use & Copyrights |
ZIB-154 | Consequenties opsplitsing Medicatie bouwstenen voor overige bouwstenen. |
ZIB-200 | Naamgeving SNOMED CT in tagged values klinische bouwstenen gelijk getrokken. |
ZIB-201 | Naamgeving OID: in tagged value notes van klinische bouwstenen gelijk getrokken. |
ZIB-309 | EOI aangepast |
ZIB-324 | Codelijsten Name en Description beginnen met een Hoofdletter |
ZIB-326 | Tekstuele aanpassingen conform de kwaliteitsreview kerngroep 2015 |
Publicatieversie 1.2.1 (22-05-2015)
ZIB-388 | De ToedieningswegCodelijst heeft geen "OID: " aanduiding in de onderliggende codelijst. |
Publicatieversie 1.2.2 (16-07-2015)
ZIB-418 | Vervallen SNOMED CT code in DrugsOfGeneesmiddelSoortCodelijst |
Publicatieversie 3.0 (01-05-2016)
ZIB-453 | Wijziging naamgeving ZIB's en logo's door andere opzet van beheer |
Publicatieversie 3.1 (04-09-2017)
ZIB-475 | Terminologiekoppeling Drugsgebruik |
ZIB-488 | niet compleet |
ZIB-505 | Geen informatie |
ZIB-512 | Hoe houd je verschillende adresgegevens uit elkaar? |
ZIB-564 | Aanpassing/harmonisatie Engelse conceptnamen |
Publicatieversie 3.2 (31-12-2017)
ZIB-555 | Uitbreiding codelijst van ZIB DrugsGebruik |
.
Concept
Drugs (or: narcotics, amphetamines, intoxicants, highs, hallucinogenics, illegal substances or dope) is a collective term for drugs and chemical substances with a more or less ‘drugging' (anesthetic, boosting and/or hallucinogenic) effect and which can lead to addiction. Drug [Online] Available at: nl.Wikipedia.org/wiki/drug [Accessed: 11 February 2015].
This information model describes the information asked of the patient about their drug use.
Purpose
Documenting and sharing registration of the drug use, as described in the concept.
Evidence Base
Though this information model can also be used to abuse (the patient’s own) medication, the project group eventually decided to focus on information on drug use, as described in the concept.
Seeing as there is a large variety of ways to record the amount of drugs used, we decided that this part is to be entered as free text.
Information Model
![DrugUse-v3.2Model(2018EN).png](/images/0/07/DrugUse-v3.2Model%282018EN%29.png)
Type | Id | Concept | Card. | Definition | DefinitionCode | Reference | ||||||||
![]() |
NL-CM:7.4.1 | ![]() |
Root concept of the DrugUse information model. This concept contains all data elements of the DrugUse information model. | |||||||||||
![]() |
NL-CM:7.4.5 | ![]() |
0..1 | Container for ObservationOfUse. This container contains all data elements of the ObservationOfUse container. | ||||||||||
![]() |
NL-CM:7.4.6 | ![]() |
0..1 | The date on which the patient started using. | ||||||||||
![]() |
NL-CM:7.4.7 | ![]() |
0..1 | The date on which the patient quit using | ||||||||||
![]() |
NL-CM:7.4.8 | ![]() |
0..1 | The number of units (pills, joints, shots etc.) per day, week, month or year or the frequency of use. | ||||||||||
![]() |
NL-CM:7.4.9 | ![]() |
0..1 | Relevant comments on the drug use. |
|
|||||||||
![]() |
NL-CM:7.4.2 | ![]() |
0..1 | Type of drug used by the patient. |
| |||||||||
![]() |
NL-CM:7.4.3 | ![]() |
1 | Indication stating whether there was any drug use in the past or present. |
|
| ||||||||
![]() |
NL-CM:7.4.4 | ![]() |
0..* | The way the drugs are used. |
|
|
Columns Concept and DefinitionCode: hover over the values for more information
For explanation of the symbols, please see the legend page
Example Instances
Only available in Dutch
DrugsOfGeneesmiddel | Drugs Gebruik Status | Start datum | Stop datum | Toedieningsweg | Hoeveelheid | Toelichting |
XTC | misbruikt drugs | 1985 | oraal | 2x per maand | Op feestjes en in uitgaanscircuit. Vroeger wat meer dan tegenwoordig. | |
DrugsOfGeneesmiddel | Drugs Gebruik Status | Start datum | Stop datum | Toedieningsweg | Hoeveelheid | Toelichting |
Heroïne | heeft in het verleden drugs gebruikt | 1970 | 1985 | intraveneus | 3x per week |
Instructions
The 'DrugOrMedicationTypeCodelist is extensible. If the drug in question is not on the codelist, the list can be extended with a code from the SNOMED CT hierarchy 'Substance; <105590001' or if necessary from the hierarchy 'Pharmaceutical/biologic product; < 373873005'.
Valuesets
DrugUseStatusCodelist
Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2 | Binding: Extensible |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Misuses drugs | 361055000 | SNOMED CT | 2.16.840.1.113883.6.96 | gebruikt drugs |
Does not misuse drugs | 228367002 | SNOMED CT | 2.16.840.1.113883.6.96 | gebruikt geen drugs |
Has never misused drugs | 228368007 | SNOMED CT | 2.16.840.1.113883.6.96 | heeft nooit drugs gebruikt |
Misused drugs in past | 44870007 | SNOMED CT | 2.16.840.1.113883.6.96 | heeft in het verleden drugs gebruikt |
Other | OTH | NullFlavor | 2.16.840.1.113883.5.1008 | anders |
RouteOfAdministrationCodelist
Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3 | Binding: Extensible |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
ORAAL | 9 | G-Standaard Toedieningswegen | 2.16.840.1.113883.2.4.4.9 | oraal |
NASAAL | 6 | G-Standaard Toedieningswegen | 2.16.840.1.113883.2.4.4.9 | nasaal (snuiven) |
INHALATIE | 62 | G-Standaard Toedieningswegen | 2.16.840.1.113883.2.4.4.9 | Inhalatie (roken) |
INTRAVENEUS | 5 | G-Standaard Toedieningswegen | 2.16.840.1.113883.2.4.4.9 | Intraveneus (spuiten) |
Other | OTH | NullFlavor | 2.16.840.1.113883.5.1008 | Anders |
TypeOfDrugOrMedicationCodelist
Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1 | Binding: Extensible |
Conceptname | Conceptcode | Codesystem name | Codesystem OID | Description |
Diamorphine | 387341002 | SNOMED CT | 2.16.840.1.113883.6.96 | Heroïne |
Benzodiazepine | 372664007 | SNOMED CT | 2.16.840.1.113883.6.96 | Benzodiazepine |
Methadone | 387286002 | SNOMED CT | 2.16.840.1.113883.6.96 | Methadon |
Hydroxybutyric acid | 62821004 | SNOMED CT | 2.16.840.1.113883.6.96 | GHB |
Cocaine | 387085005 | SNOMED CT | 2.16.840.1.113883.6.96 | Cocaïne |
Cocaine freebase | 229003004 | SNOMED CT | 2.16.840.1.113883.6.96 | Crack, base coke |
Methylenedioxymethamphetamine | 288459003 | SNOMED CT | 2.16.840.1.113883.6.96 | MDMA |
Amphetamine | 703842006 | SNOMED CT | 2.16.840.1.113883.6.96 | Amfetamine, speed |
Cannabis | 398705004 | SNOMED CT | 2.16.840.1.113883.6.96 | Cannabis, wiet marihuana, hasj |
Hallucinogenic mushrooms | 229006007 | SNOMED CT | 2.16.840.1.113883.6.96 | Paddos |
Lysergic acid diethylamide | 15698006 | SNOMED CT | 2.16.840.1.113883.6.96 | LSD |
Ketamine | 373464007 | SNOMED CT | 2.16.840.1.113883.6.96 | Ketamine |
Phencyclidine | 9721008 | SNOMED CT | 2.16.840.1.113883.6.96 | PCP |
Metamfetamine | 387499002 | SNOMED CT | 2.16.840.1.113883.6.96 | Crystal meth, methamfetamine |
Anabolic steroid | 111151007 | SNOMED CT | 2.16.840.1.113883.6.96 | Anabole steroïde |
Laxative | 372800002 | SNOMED CT | 2.16.840.1.113883.6.96 | Laxans |
Buprenorphine | 387173000 | SNOMED CT | 2.16.840.1.113883.6.96 | Buprenorfine |
Fentanyl | 373492002 | SNOMED CT | 2.16.840.1.113883.6.96 | Fentanyl |
Barbiturate | 372798009 | SNOMED CT | 2.16.840.1.113883.6.96 | Barbituraat |
Other | OTH | NullFlavor | 2.16.840.1.113883.5.1008 | Anders |
This information model in other releases
- Release 2015, (Version 1.2.2)
- Release 2016, (Version 3.0)
- Release 2017, (Version 3.2)
- Prerelease 2019-2, (Version 3.2)
- Release 2020, (Version 3.3)
- Prerelease 2021-2, (Version 3.4)
- Prerelease 2022-1, (Version 3.4)
- Prerelease 2023-1, (Version 3.4.1)
- Prerelease 2024-1, (Version 3.5)
Information model references
This information model refers to
- --
This information model is used in
- --
Technical specifications in HL7v3 CDA and HL7 FHIR
To exchange information based on health and care information models, additional, more technical specifications are required.
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
- HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment
- HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR
Downloads
This information model is also available as pdf file or as spreadsheet
About this information
The information in this wikipage is based on Prerelease 2018 #1
SNOMED CT and LOINC codes are based on:
- SNOMED Clinical Terms version: 20180731 [R] (July 2018 Release)
- LOINC version 2.64
Conditions for use are located on the mainpage
This page is generated on 23/12/2018 01:17:22 with ZibExtraction v. 3.0.6929.24609